2nd Quarter - Report

LUNDBECK LLC for LUNDBECK LLC

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to Pharmacy Benefit Managers Step therapy reform -the Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Approps BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Approps

LobbyistCovered position, as disclosed
HAYLEY ALEXANDER New —
HEATHER STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues pertaining to the 340B Drug Discount Program Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 - The ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832 - The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 1 - One Big Beautiful Bill Act

LobbyistCovered position, as disclosed
HAYLEY ALEXANDER New —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 946 (119th), H.R. 1492 (119th), S. 832 (119th), H.R. 1 (119th)

Taxation/Internal Revenue Code TAX

R&D Tax Credit

LobbyistCovered position, as disclosed
HAYLEY ALEXANDER —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Tariffs on pharmaceutical products

LobbyistCovered position, as disclosed
HAYLEY ALEXANDER —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.